Download Files:
Yohimbine (Hydrochloride)
$30 – $50
Web ID
– HY-N0127
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Molecular Formula
– C21H27ClN2O3
Citations
– Eur J Pharmacol. 2023 Nov 6:176174.|Exp Neurobiol. 2020 Oct 31;29(5):356-375.|Mol Biol Rep. 2020 May;47(5):3629-3639.|Mol Med Rep. 2020 Jul;22(1):175-184.|Neurosci Bull. 2022 Apr;38(4):386-402.|Biomed Pharmacother. 2022 Apr 26;150:113006.|Eur J Neurosci. 2021 Nov 4.|J Neuroinflammation. 2022 May 27;19(1):123.|J Neurophysiol. 2023 Apr 12.
References
– [1]Docherty JR, et al. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4.. . . .|[2]Docherty JR, et al. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4.. . . .|[3]Docherty JR, et al. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4.
CAS Number
– 65-19-0
Molecular Weight
– 390.90
Compound Purity
– 99.89
SMILES
– [H][C@]12C(NC3=C4C=CC=C3)=C4CCN1C[C@@]5(CC[C@H](O)[C@H](C(OC)=O)[C@]5(C2)[H])[H].[H]Cl
Clinical Information
– Launched
Research Area
– Endocrinology
Solubility
– DMSO : 33.33 mg/mL (ultrasonic)|H2O : 3.33 mg/mL (ultrasonic)
Target
– Adrenergic Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Natural Products
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
